Search results
Herpes simplex viruses, HSV-1 and HSV-2, are highly contagious and cause lifelong, latent infections with recurrent outbreaks of oral and/or genital lesions. No cure exists for HSV-1 or HSV-2 infections, but antiviral medications are commonly used ...
In this study, we examined the potential of Echinacea purpurea in preventing and treating respiratory tract infections (RTIs) and in particular, SARS-CoV-2 infections. 120 healthy volunteers (m,f, 18—75 years) were randomly assigned to Echinacea prevention or control group without any intervention.
1 lut 2021 · Echinacea have been shown to be effective against rhinoviruses [121], influenza virus [122], RSV [44], herpes virus [44], adenoviruses [44], and coronaviruses [43, 123]. Another compound, chicoric acid, has also shown potent antiviral effects against herpes simplex, influenza, enterovirus, hepatitis B virus, HIV, vaccinia virus, and vesicular ...
25 kwi 2022 · Abstract. The development of vaccines against herpes simplex virus type 1 and type 2 (HSV1 and HSV-2) is an important goal for global health.
15 gru 2022 · In this study, H. perforatum (St. John’s Wort) and Echinacea were tested in vitro using Vero E6 cells for their anti-viral effects against the newly identified Severe Acute Respiratory Syndrome...
26 kwi 2022 · EF exhibited antiviral effects and reduced the risk of viral RTIs, including SARS-CoV-2. By substantially reducing virus loads in infected subjects, EF offers a supportive addition to existing mandated treatments like vaccinations. Future confirmatory studies are warranted.
13 lip 2011 · Early reports of antiviral activity of Echinacea indicated that several different methanol and aqueous extracts derived from E. purpurea could partially protect cultured cells from infection by influenza A virus, herpes simplex virus type 1, or vesicular stomatitis, viruses. This suggested an intracellular inhibition, although the possibility ...
